STEM - .884 This is due for a bounce. StemCells, Inc. Transplants First Participant in Phase II Clinical Trial in Cervical Spinal Cord Injury stockcharts.com/c-sc/sc?s=STEM&p=D&b=5&g=0&i=0&r=1418909202785